Triple-drug transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: assessment of survival in 124 consecutive patients

AJR. American Journal of Roentgenology
Antoinette S GomesRonald W Busuttil

Abstract

The objective of our study was to describe survival outcome in 124 patients with unresectable hepatocellular carcinoma treated with triple-drug transcatheter arterial chemoembolization (TACE) using doxorubicin, cisplatin, and mitomycin C using a standardized regimen. One hundred twenty-four patients underwent TACE using a standardized triple-drug regimen. Embolization was performed using subselective coaxial embolization technique. Fifty-six patients (group 1) received triple-drug TACE in conjunction with a nonpermanent embolic agent, microfibrillar collagen (Avitene), and 68 patients (group 2) had triple-drug TACE with a permanent embolic agent, Embosphere Microspheres. Twenty-eight patients underwent liver transplantation after TACE, and survival in these patients was significantly longer than those who did not receive a transplant (p < or = 0.001). The mean survival for the no-transplant group (n = 96) was longer in patients with Child-Pugh class A cirrhosis than in those with Child-Pugh class B cirrhosis (30.3 +/- 2.92 [standard error] vs 11.6 +/- 2.84 months, respectively; p < 0.001), in those with Okuda stage I versus stage II disease (31.4 +/- 3.03 vs 17.4 +/- 3.16 months; p = 0.002), and in those with a pre-TACE bilirub...Continue Reading

References

May 1, 1978·Investigative Radiology·S L KaufmanR I White
Mar 1, 1991·Cardiovascular and Interventional Radiology·N NakaoT Miura
Feb 1, 1987·Investigative Radiology·J R DanielsE J Ring
May 11, 1995·The New England Journal of Medicine·UNKNOWN Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire
Aug 1, 1994·AJR. American Journal of Roentgenology·R L Baron
May 1, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Chung-Mau LoJohn Wong
Aug 1, 2002·Nature Genetics·Snorri S Thorgeirsson, Joe W Grisham
Jan 24, 2003·AJR. American Journal of Roentgenology·Yumi NoguchiHironobu Nakamura
Jan 24, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Josep M Llovet, Jordi Bruix
Dec 24, 2005·Journal of Vascular and Interventional Radiology : JVIR·Daniel B BrownJeffrey S Crippin
Aug 8, 2006·Gastroenterology·Kenichi TakayasuUNKNOWN Liver Cancer Study Group of Japan

❮ Previous
Next ❯

Citations

Jul 19, 2012·International Journal of Clinical Oncology·Keigo OsugaNoriyuki Tomiyama
Jun 23, 2011·Expert Opinion on Drug Delivery·Antonio NicoliniLaura Martinetti
May 25, 2010·Seminars in Oncology·John R Daniels, Melissa Wallman
Apr 9, 2015·World Journal of Gastroenterology : WJG·Jing-Huan LiZheng-Gang Ren

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.